AMENDMENT TO AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENTLicense, Development and Commercialization Agreement • April 19th, 2010 • Vanda Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledApril 19th, 2010 Company IndustryThis Amendment to Amended and Restated License, Development and Commercialization Agreement (the “Amendment”) is entered into effective as of April 15, 2010 (the “Effective Date”) by and between Vanda Pharmaceuticals Inc., a Delaware corporation (“Vanda”), and Bristol-Myers Squibb Company, a Delaware corporation (“BMS”).